<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nemec KM</submitter><funding>NIA NIH HHS</funding><funding>NIH Office of the Director</funding><funding>NIAID NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>The Paul Allen Frontiers Group</funding><funding>Blavatnik Family Foundation</funding><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Institute of Health</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><funding>National Science Foundation</funding><funding>Esther A. and Joseph Klingenstein Fund</funding><pagination>RP102900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12844908</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14</volume><pubmed_abstract>Microglia, the brain's resident macrophages, can be reconstituted by surrogate cells - a process termed 'microglia replacement'. To expand the microglia replacement toolkit, we here introduce estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized macrophages, a cell model for generation of immune cells from murine bone marrow, as a versatile model for microglia replacement. We find that ER-Hoxb8 macrophages are highly comparable to primary bone marrow-derived macrophages in vitro, and, when transplanted into a microglia-free brain, engraft the parenchyma and differentiate into microglia-like cells. Furthermore, ER-Hoxb8 progenitors are readily transducible by virus and easily stored as stable, genetically manipulated cell lines. As a demonstration of this system's power for</pubmed_abstract><journal>eLife</journal><pubmed_title>Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutieres syndrome neuropathology.</pubmed_title><pmcid>PMC12844908</pmcid><funding_grant_id>R01AI139544</funding_grant_id><funding_grant_id>Blavatnik Family Fellowship</funding_grant_id><funding_grant_id>NIH T32 GM008076</funding_grant_id><funding_grant_id>DGE-1845298</funding_grant_id><funding_grant_id>GRT-00000774</funding_grant_id><funding_grant_id>R01NS120960</funding_grant_id><funding_grant_id>R15 NS133939</funding_grant_id><funding_grant_id>Fellowship Award in Neuroscience</funding_grant_id><funding_grant_id>R01 AI139544</funding_grant_id><funding_grant_id>R01 NS120960</funding_grant_id><funding_grant_id>T32-AG-000255-26</funding_grant_id><funding_grant_id>T32 GM008076</funding_grant_id><funding_grant_id>DP5 OD036159</funding_grant_id><funding_grant_id>DP5OD036159</funding_grant_id><funding_grant_id>T32MH019112</funding_grant_id><funding_grant_id>T32 MH019112</funding_grant_id><funding_grant_id>R15NS133939</funding_grant_id><funding_grant_id>R35GM138085</funding_grant_id><funding_grant_id>R01 NS134651</funding_grant_id><funding_grant_id>R35 GM138085</funding_grant_id><funding_grant_id>R01NS134651</funding_grant_id><funding_grant_id>T32 GM007170</funding_grant_id><funding_grant_id>T32 AG000255</funding_grant_id><pubmed_authors>Nemec KM</pubmed_authors><pubmed_authors>Uy G</pubmed_authors><pubmed_authors>Purnell FS</pubmed_authors><pubmed_authors>Thaiss CA</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Oon CH</pubmed_authors><pubmed_authors>O'Reilly ML</pubmed_authors><pubmed_authors>O'Brien CA</pubmed_authors><pubmed_authors>Elfayoumi B</pubmed_authors><pubmed_authors>Lombroso SI</pubmed_authors><pubmed_authors>Byerly L</pubmed_authors><pubmed_authors>Chaluvadi VS</pubmed_authors><pubmed_authors>Williamson AP</pubmed_authors><pubmed_authors>Bennett ML</pubmed_authors><pubmed_authors>Blank N</pubmed_authors><pubmed_authors>Rawat P</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Bennett FC</pubmed_authors><pubmed_authors>Yaqoob F</pubmed_authors><pubmed_authors>Bailis W</pubmed_authors><pubmed_authors>Aisenberg WH</pubmed_authors><pubmed_authors>Temsamrit B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutieres syndrome neuropathology.</name><description>Microglia, the brain's resident macrophages, can be reconstituted by surrogate cells - a process termed 'microglia replacement'. To expand the microglia replacement toolkit, we here introduce estrogen-regulated (ER) homeobox B8 (Hoxb8) conditionally immortalized macrophages, a cell model for generation of immune cells from murine bone marrow, as a versatile model for microglia replacement. We find that ER-Hoxb8 macrophages are highly comparable to primary bone marrow-derived macrophages in vitro, and, when transplanted into a microglia-free brain, engraft the parenchyma and differentiate into microglia-like cells. Furthermore, ER-Hoxb8 progenitors are readily transducible by virus and easily stored as stable, genetically manipulated cell lines. As a demonstration of this system's power for</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-14T21:03:49.846Z</modification><creation>2026-06-25T03:08:16.632Z</creation></dates><accession>S-EPMC12844908</accession><cross_references><pubmed>41589671</pubmed><doi>10.7554/eLife.102900</doi></cross_references></HashMap>